Examining geographic accessibility to radiotherapy in Canada and Greenland for indigenous populations: Measuring inequities to inform solutions.

Access Canada Geographic Information System Greenland Indigenous Radiotherapy

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
05 2020
Historique:
received: 01 12 2019
revised: 22 01 2020
accepted: 27 01 2020
pubmed: 18 2 2020
medline: 15 4 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

A high cancer burden exists among indigenous populations worldwide. Canada and Greenland have similar geographic features that make health service delivery challenging. We sought to describe geographic access to radiotherapy for indigenous populations in both regions. We used geospatial analyses to calculate distance and travel-time from indigenous communities in Canada and Greenland to the nearest radiotherapy center. We calculated the proportion of indigenous communities and populations residing within a 1 and 2-hour drive of a radiotherapy center in Canada, and compared the proportion of indigenous versus non-indigenous populations residing within each drive-time area. We calculated the potential distance and travel-time saved if radiotherapy was available in northern Canada (Yellowknife and Iqaluit), and Greenland (Nuuk). Median one-way travel from indigenous communities to nearest radiotherapy center in Canada was 268 km (3 h when considering any transportation mode), and 4111 km (6 h by plane) in Greenland. In Canada, 84% and 68% of indigenous communities were outside a 1 and 2-hour drive from a radiotherapy center, respectively. Only 2% of the total population in Canada resided outside a 2-hour drive from a radiotherapy center. However, indigenous peoples were 336 times more likely to live more than a 2-hour drive away, compared to non-indigenous peoples. Nearly 3 million km and 4000 h of travel could be saved over a 10-year period for patients with newly diagnosed cancers in Canada, and 7 million km and 10,000 h in Greenland, if radiotherapy was available in Yellowknife, Iqaluit and Nuuk. Geography is an important barrier to accessing radiotherapy for indigenous populations in Canada and Greenland. A significant disparity exists between indigenous and non-indigenous peoples in Canada. Geospatial analyses can help highlight disparities in access to inform radiotherapy service planning.

Sections du résumé

BACKGROUND
A high cancer burden exists among indigenous populations worldwide. Canada and Greenland have similar geographic features that make health service delivery challenging. We sought to describe geographic access to radiotherapy for indigenous populations in both regions.
METHODS
We used geospatial analyses to calculate distance and travel-time from indigenous communities in Canada and Greenland to the nearest radiotherapy center. We calculated the proportion of indigenous communities and populations residing within a 1 and 2-hour drive of a radiotherapy center in Canada, and compared the proportion of indigenous versus non-indigenous populations residing within each drive-time area. We calculated the potential distance and travel-time saved if radiotherapy was available in northern Canada (Yellowknife and Iqaluit), and Greenland (Nuuk).
RESULTS
Median one-way travel from indigenous communities to nearest radiotherapy center in Canada was 268 km (3 h when considering any transportation mode), and 4111 km (6 h by plane) in Greenland. In Canada, 84% and 68% of indigenous communities were outside a 1 and 2-hour drive from a radiotherapy center, respectively. Only 2% of the total population in Canada resided outside a 2-hour drive from a radiotherapy center. However, indigenous peoples were 336 times more likely to live more than a 2-hour drive away, compared to non-indigenous peoples. Nearly 3 million km and 4000 h of travel could be saved over a 10-year period for patients with newly diagnosed cancers in Canada, and 7 million km and 10,000 h in Greenland, if radiotherapy was available in Yellowknife, Iqaluit and Nuuk.
CONCLUSIONS
Geography is an important barrier to accessing radiotherapy for indigenous populations in Canada and Greenland. A significant disparity exists between indigenous and non-indigenous peoples in Canada. Geospatial analyses can help highlight disparities in access to inform radiotherapy service planning.

Identifiants

pubmed: 32065874
pii: S0167-8140(20)30042-6
doi: 10.1016/j.radonc.2020.01.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Jessica Chan (J)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada; Department of Radiation Oncology, Amsterdam UMC - Vrije University Medical Center, Amsterdam, The Netherlands. Electronic address: jchan207@uottawa.ca.

Jeppe Friborg (J)

Department of Clinical Oncology, Rigshospitalet, Copenhagen, Denmark.

Eduardo Zubizarreta (E)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria.

Jan Willem van Eck (JW)

Environmental Systems Research Institute, The Netherlands.

Timothy P Hanna (TP)

Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.

Jean-Marc Bourque (JM)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada; Institute of Cancer Policy, Kings College London, Guy's Hospital, London, United Kingdom; Department of Medicine, McGill University, Montreal, Canada.

Marc Gaudet (M)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada.

Kristopher Dennis (K)

Division of Radiation Oncology, The Ottawa Hospital and the University of Ottawa, Canada.

Robert Olson (R)

BC Cancer Centre for the North, Prince George, Canada.

C Norman Coleman (CN)

International Cancer Expert Corps, Inc., Washington DC, USA.

Alice J Petersen (AJ)

Department of Medicine, Queen Ingrid's Hospital, Nuuk, Greenland.

Cai Grau (C)

Department of Oncology and the Danish Center for Particle Therapy, Aarhus University Hospital, Denmark.

May Abdel-Wahab (M)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria.

Michael Brundage (M)

Division of Cancer Care and Epidemiology, Cancer Research Institute at Queen's University, Kingston, Canada.

Ben Slotman (B)

Department of Radiation Oncology, Amsterdam UMC - Vrije University Medical Center, Amsterdam, The Netherlands.

Alfredo Polo (A)

Division of Human Health, International Atomic Energy Agency, Vienna, Austria. Electronic address: J.A.Polo-Rubio@iaea.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH